指南与共识质量管理与危急值临床生化临床血液与体液

明智选择倡议:检验相关推荐意见的证据评估

Choosing Wisely - avoiding medical overuse: evidence assessment of recommendations on laboratory parameters.
指南 / 共识 · Clin Chem Lab Med · 2026-07-21

本研究检索美国、英国、德国、瑞士和奥地利五国明智选择网站中检验相关推荐,去除重复后随机选取49条独特推荐,按牛津2009证据等级评估其证据质量。结果显示58%基于高证据(I-II级),14%为中等(III级),18%为低证据(IV-V级),10%无法分类;血液学、输血/凝血和肿瘤领域I级证据最多(75%),感染、儿科和生殖医学更多依赖V级来源(各29%)。

要点

  • 58%的检验相关推荐基于高证据(I-II级),但仍有18%基于低证据(IV-V级)。
  • 血液学、输血/凝血和肿瘤领域I级证据比例最高(75%)。
  • 感染、儿科和生殖医学更多依赖V级来源(各29%)。

核心结论

  • 部分明智选择检验相关推荐基于高证据,另一些缺乏强实证支持。
  • 需定期更新高质量研究、加强国际合作并提高透明度以改善证据基础和患者照护。

研究设计与样本

  • 检索五国(美国、英国、德国、瑞士、奥地利)明智选择网站的检验相关推荐。
  • 去除重复后随机选取49条独特推荐,按专业分类并用牛津2009系统评估证据质量。

主要发现

  • 49条推荐中58%基于高证据(I-II级),14%基于中等证据(III级),18%基于低证据(IV-V级),10%无法分类。
  • 血液学、输血/凝血医学和肿瘤领域I级证据最多(75%)。
  • 感染学、儿科和生殖医学更多依赖V级来源(各29%)。
  • 跨国比较显示检验医学推荐存在显著差异,反映各国医疗优先事项不同。

关键数值与推荐

  • 证据评级采用牛津2009系统,依据原作者引用的来源。
  • 指南按支持推荐的研究类型评级;叙述性综述和专家意见因方法学较弱给予较低证据等级,即使引用了更高质量研究。
  • 从提供的来源中分配最高可能的证据等级。

临床怎么用

  • 检验科医生可参考明智选择推荐减少不必要检验,但需注意部分推荐证据等级较低。
  • 在应用推荐时应结合本地证据和患者情况,对低证据推荐保持审慎。

局限性

  • 仅随机选取49条独特推荐,样本量有限。
  • 证据评估基于原始作者引用的来源,可能受引用偏倚影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Launched in 2012, the Choosing Wisely initiative promotes evidence-based recommendations to reduce unnecessary tests and treatments. This study reviewed laboratory-related recommendations from five countries (USA, UK, Germany, Switzerland, and Austria) to assess their scientific validity. METHODS: Choosing Wisely websites were searched for laboratory-related recommendations. After removing duplicates, 49 randomly selected unique recommendations remained for this study. They were categorized by specialty and assessed for evidence quality using the Oxford 2009 system based on the sources cited by the original authors. Guidelines were rated by the study types supporting the recommendation, while narrative reviews and expert opinions received a lower level of evidence due to their weaker methodology, even if higher-quality studies were cited. The highest possible level of evidence was assigned from the sources provided. RESULTS: Of 49 Choosing Wisely recommendations 58 % were based on high evidence (levels I-II), 14 % on moderate evidence (level III), 18 % on low evidence (level IV-V) and 10 % could not be classified. Hematology, transfusion/coagulation medicine, and oncology had the most level I evidence (75 %), while infectiology, pediatrics, and reproductive medicine relied more on level V sources (each 29 %). Cross-country comparison showed notable differences in the recommendations for laboratory medicine, reflecting national priorities in healthcare. CONCLUSIONS: Some of Choosing Wisely's laboratory-related recommendations are based on a high level of evidence, while others lack strong empirical support. Regular updates with high-quality research, international collaboration, and greater transparency are needed to improve the evidence base and patient care.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Beri C, Engel D, Risch M, et al. Choosing Wisely - avoiding medical overuse: evidence assessment of recommendations on laboratory parameters. Clin Chem Lab Med. 2026. PMID: 42478959. doi:10.1515/cclm-2026-0358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。